Abstract
Secretory lysosomes are required for the specialised functions of various types of differentiated cells. In osteoclasts, the lysosomal proton pump V-ATPase (vacuolar-type ATPase) is targeted to the plasma membrane via secretory lysosomes and subsequently acidifies the extracellular compartment, providing optimal conditions for bone resorption. However, little is known about the mechanism underlying this trafficking of secretory lysosomes. Here, we demonstrate that the lysosome-specific a3 isoform of the V-ATPase a subunit plays an indispensable role in secretory lysosome trafficking, together with Rab7, a small GTPase involved in organelle trafficking. In osteoclasts lacking a3, lysosomes were not transported to the cell periphery, and Rab7 was not localised to lysosomes but diffused throughout the cytoplasm. Expression of dominant-negative (GDP-bound form) Rab7 inhibited lysosome trafficking in wild-type cells. Furthermore, a3 directly interacted with the GDP-bound forms of Rab7 and Rab27A. These findings reveal a novel role for the proton pump V-ATPase in secretory lysosome trafficking and an unexpected mechanistic link with Rab GTPases.
Introduction
Trafficking of organelles and membrane vesicles is indispensable for various types of cargo transport, including endocytosis and secretion. For example, bacterial toxins and low-density lipoprotein are internalised via endocytosis, transported to lysosomes, their final destination, and enzymatically digested in acidic conditions1,2. Lysosomes can also move in an anterograde direction and fuse with the plasma membrane, leading to secretion3,4. These so-called “secretory lysosomes” contain secretory proteins and hydrolysing enzymes3,4. Such lysosomes, which are observed in several cell types including platelets, spermatids and those involved in the immune system, are responsible for the specialised functions of various differentiated cells3–6. Melanocytes secrete melanin via lysosome-related organelles called melanosomes, leading to pigmentation7. Cytotoxic T lymphocytes and natural killer cells secrete a pore-forming protein via lysosomes to kill cells that need to be removed8,9. Defects of genes related to secretory lysosomes cause albinism and immunodeficiency in human and mouse10,11.
Secretory lysosomes are also indispensable in osteoclasts, which are involved in bone resorption3,4,12. These cells differentiate from progenitors upon stimulation with receptor activator of nuclear factor kappa B ligand (RANKL)13, attach to the bone surface via actin rings and form a resorption lacuna, an acidic compartment facing the bone surface14–16. Lysosomes with vacuolar-type ATPase (V-ATPase) in their membrane move to the periphery of osteoclasts and fuse with the plasma membrane12,17,18. Thereafter, lysosomal enzymes are secreted into the bone resorption lacuna12,19,20. Lysosomal V-ATPase that has relocalised to the plasma membrane acidifies the lacuna, providing optimal conditions for bone digestion and dissolution of calcium phosphate17,18,21.
V-ATPase, composed of catalytic V1 and proton pathway Vo sectors, transports protons across the membrane using energy obtained via ATP hydrolysis22,23. Six of the thirteen subunits that form mammalian V-ATPases have multiple isoforms specific to an organelle and/or type of differentiated cells24–26. Of the four a subunit isoforms forming a proton pathway in Vo, a1, a2 and a3 are expressed ubiquitously, whereas a4 is expressed specifically in renal, reproductive and optic organs23–26. The a1, a2 and a3 isoforms are found in coated vesicles, early endosomes/Golgi apparatus and late endosomes/lysosomes, respectively23–26. Of the two d subunit isoforms connecting V1 and Vo, d2 was recently shown to be osteoclast-specific27–30. Osteoclast V-ATPase mostly contains the a3 and d2 isoforms, and expression of both is significantly induced during differentiation30. Genetic defects of a3 increase bone density and thereby cause severe osteopetrosis in humans (OMIM 604592)31. In a3-deficient mice, osteoclasts fail to transport protons and exhibit impaired bone resorption32,33. Previous studies focused on a3 as an essential isoform of V-ATPase for acidification of lacunae.
Small GTPases belonging to the Rab family are key regulators of organelle trafficking34,35. More than 60 Rab proteins have been identified in mammalian cells36,37. Individual Rab proteins are recruited from the cytosol to distinct organelles or vesicles and connect them to the microtubule or actin cytoskeleton, in cooperation with specific effector proteins and other machinery34,35,38. The activities of Rab proteins are regulated by guanine nucleotides, with the GTP- and GDP-bound forms being active and inactive, respectively34,35,38. Reduced expression of Rab7 and Rab27A in osteoclasts results in impaired bone resorption, indicating that these proteins are involved in lysosomal secretion39,40. Despite recent intensive studies, the mechanism by which individual Rab proteins are recruited to specific organelles/vesicles remains to be elucidated.
Here, we demonstrate that the a3 isoform of V-ATPase has dual function in osteoclasts: it is essential not only for lacunae acidification, but also for secretory lysosome trafficking via Rab protein recruitment. We elucidate the mechanism underlying lysosome trafficking, demonstrating an unexpected link between the V-ATPase a3 isoform and Rab small GTPases.
Results
Localisation of lysosomal membrane proteins in osteoclasts from a3-knockout mice
Osteoclasts, multinuclear cells that face the bone matrix, were observed in the humeral epiphysis of wild-type and a3-knockout mice by electron microscopy (Fig. 1a), confirming previous results32,41. These cells had peripheral clear zones (actin rings) and a characteristic ruffled border (Fig. 1b, blue and orange, respectively). We defined the cytoplasm of osteoclasts as all areas apart from the peripheral clear zones, nucleus and ruffled border (Fig. 1b, green). In higher magnification images, finger-like folds of the ruffled border were clearly identified (Fig. 1c). These results indicate that the a3 isoform is not essential for formation of lacunae. However, the bone matrix of mutant mice was electron-opaque compared with that of wild-type mice (Fig. 1a), suggesting that a3-deficient mice developed osteopetrosis. We also observed electron-dense material between processes of the ruffled border in mutant mice (Fig. 1c, arrowheads).
Immunoelectron microscopy revealed that CD68 and cathepsin K, a trans-membrane lysosomal/late endosomal protein and a lysosomal protease, respectively, co-localised in organelles (100–450 nm diameter) in wild-type osteoclasts (Fig. 2a, magenta and green arrowheads, respectively). CD68 and cathepsin K also co-localised in a3-knockout cells (Fig. 2a). These results indicate that lysosomes in mutant and wild-type osteoclasts contained both cathepsin K and CD68.
Gold particles labelling CD68 were observed in the ruffled border membrane of wild-type osteoclasts (Fig. 2b, WT), consistent with the previous results indicating that secretory lysosomes fused with this membrane21,42. However, gold particles were rarely observed in the ruffled border of a3-knockout osteoclasts (Fig. 2b, a3KO). These particles were found in cytoplasmic organelles in both wild-type and a3-knockout osteoclasts (Fig. 2b, Cytoplasm).
The distribution of CD68 was determined by counting the number of gold particles in 30 randomly selected fields of the ruffled border and cytoplasm (Fig. 2c). There was a mean of 32.0 ± 2.0 and 2.0 ± 0.3 particles per field (1.4 μm2) in the ruffled border of wild-type and mutant osteoclasts, respectively. On the other hand, the number of gold particles in the cytoplasm was similar in wild-type and mutant osteoclasts. These results indicate that relocation of lysosomal CD68 to the cell surface is defective in a3-knockout osteoclasts.
Lysosome trafficking in osteoclasts derived from mouse splenic macrophages
Trafficking of lysosomes to the plasma membrane was further studied in osteoclasts derived from splenic macrophages. Wild-type macrophages began to fuse after incubation with RANKL for 2 days and differentiated into multinuclear cells expressing the osteoclast marker tartrate-resistant acid phosphatase (TRAP) (Supplementary Fig. S1a, WT). Mutant macrophages differentiated into multinuclear osteoclasts with almost the same kinetics as wild-type macrophages (Supplementary Fig. S1a, a3KO). In addition, the numbers of TRAP-positive fused cells derived from mutant and wild-type macrophages were almost the same. However, mutant osteoclasts did not form any resorption pits when cultured on a calcium phosphate substrate mimicking bone30 (Supplementary Fig. S1b).
We then examined the localisations of the lysosomal protein CD68, α-tubulin and F-actin by immunostaining and phalloidin staining17,30. In wild-type cells, CD68 was observed mainly in the perinuclear area up to 3 days after RANKL addition (Fig. 3a, CD68). After 4 days, CD68-positive organelles were located close to the cell periphery (Fig. 3a, CD68, Days 4). These results suggest that lysosomes move to the cell periphery during differentiation. In addition, α-tubulin co-localised with CD68 close to the cell periphery, and an actin ring was observed adjacent to CD68 staining (Fig. 3a,b), consistent with our previous observation in osteoclasts differentiated from the murine macrophages line RAW264.717. Unlike osteoclasts attached to bone, these cells were thin (~2 μm) and did not exhibit a highly developed ruffled border (Supplementary Fig. S1c).
In a3-knockout osteoclasts, CD68 and α-tubulin did not localise at the periphery (Fig. 3c,d), although the central microtubule network formed from tubulin and actin rings were observed (Fig. 3b,d). The central microtubule network appeared to be less radially oriented in mutant cells than in wild-type cells (Fig. 3b,d). Next, the distribution of CD68 was quantified by measuring its relative staining intensity in several sections created using the shape of the cell outline (Fig. 3e, left and middle). The relative intensity of CD68 staining was plotted against the distance from the cell edge (Fig. 3e, right). This revealed that 53% and 24% of CD68 staining was distributed within 10 μm from the edge of wild-type and a3-knockout osteoclasts, respectively. Similar results were obtained using another lysosome marker, LAMP1 (Supplementary Fig. S2).
On the other hand, GM130, a Golgi marker protein43, and EEA1, an early endosomal marker44, exhibited dot-like staining in the perinuclear region of both wild-type and a3-knockout cells (Fig. 3f,g). Taken together, these results indicate that the a3 isoform plays an essential role in outward trafficking of lysosomes and formation of the microtubule network at the cell periphery.
When mutant macrophages expressing FLAG-a3 were differentiated into osteoclasts, lysosome localisation at the cell periphery was restored to the same level as that in wild-type cells (Fig. 4a,b). Moreover, calcium phosphate resorption activity of mutant osteoclasts expressing FLAG-a3 was restored to 76% of that of wild-type cells (Fig. 4c). These results confirm that a3 is required for localisation of lysosomes at the cell periphery.
Protein levels of the a1 and a2 isoforms in mutant osteoclasts were the same as those in wild-type osteoclasts (Supplementary Fig. S3). This indicates that their expression does not increase to compensate for the lack of a3 and that these isoforms cannot perform the role of a3 in lysosome trafficking.
We investigated the localisation of CD68 in mouse osteoclasts attached to the bone surface (Fig. 2) and in those differentiated from macrophages in vitro (Fig. 3). In both cases, the peripheral localisation of lysosomes required a3, and lysosomes were transported from the perinuclear region to the cell periphery.
Effects of a3 on cytokine secretion and endocytosis
We investigated the effects of a3 knockout on other types of trafficking, namely, cytokine secretion45, endocytosis of FITC-dextran46 and cholesterol localisation47. To analyse cytokine secretion, macrophages from mutant and wild-type mice were incubated with lipopolysaccharide (LPS) for 8 or 24 h, and then the amounts of interleukin 6 (IL6) and interleukin 10 (IL10) secreted via Golgi-derived vesicles were assayed48. Secretion was quantitated as the amount of cytokine secreted into the medium against the total amount of cytokine synthesised. The percentage secretion of IL6 and IL10 by wild-type macrophages was about 100% (Fig. 5a, blue), indicating that almost all synthesised cytokine molecules were secreted. The same finding was made in mutant macrophages (Fig. 5a, magenta), indicating that a3 has no significant role in trafficking during cytokine secretion.
Next, we examined the effect of a3 knockout on endocytosis. FITC-dextran was taken up from the medium and partly localised in CD68-positive lysosomes in both wild-type and mutant macrophages (Fig. 5b, left panels). The amount of FITC-dextran taken up by mutant cells was about 75% of that taken up by wild-type cells (Fig. 5b, middle panel). Co-localisation of FITC-dextran and CD68 was also determined to assess delivery of FITC-dextran to late endosomes/lysosomes. About 18% and 16% of FITC-dextran co-localised with CD68 in wild-type and mutant cells, respectively (Fig. 5b, right panel). Although a3 knockout slightly reduced dextran uptake, these results indicate that a3 does not play an essential role in vesicle trafficking from the cell surface to late endosomes/lysosomes.
In many lysosomal storage disease (LSD) cells, accumulation of cholesterol in lysosomes promotes inward trafficking of lysosomes47. Filipin staining of cholesterol is significantly intense in the perinuclear region of these cells47. Filipin staining in the perinuclear region was similar in a3-knockout and wild-type cells (Fig. 5c, left panels), suggesting that cholesterol localisation in mutant cells is similar to that in wild-type cells. Additionally, in contrast with LSD cells, the level of cholesterol was not higher in a3-knockout cells than in wild-type cells (Fig. 5c, right panel). These results indicate that a3 has no role in the localisation or accumulation of cholesterol. Thus, the defective lysosome trafficking observed in mutant osteoclasts is not due to altered cholesterol accumulation in the perinuclear region.
Involvement of Rab small GTPases in lysosome trafficking
Rab GTPases regulate organelle trafficking and positioning by linking organelles/vesicles to cytoskeletal motor proteins34,35. Rab7 functions in transport from late endosomes to lysosomes49. Rab27A (a Rab27 isoform) is involved in secretion of lysosome-related organelles50,51. Reduced expression of these two proteins results in impaired bone metabolism39,40. Furthermore, secretory lysosomes are formed in lymphocytes via the merger of late endosomes and recycling endosomes containing Rab7/Rab27A and Rab11, respectively51,52. Of the two isoforms of Rab11, Rab11B is expressed in osteoclasts53.
To examine the roles of these Rab GTPases, we overexpressed their FLAG-tagged dominant-negative (GDP-bound), wild-type and constitutively active (GTP-bound) forms in wild-type macrophages (Fig. 6, DN, WT and CA, respectively), and then induced differentiation into osteoclasts. FLAG-tagged Rab proteins were detected by immunoblotting (Fig. 6a, upper panels, magenta arrows). FLAG-tagged and endogenous Rab proteins were simultaneously detected using specific antibodies against each Rab protein (Fig. 6a, middle panels, magenta and closed arrows, respectively). Signals of FLAG-tagged Rab proteins were markedly stronger than those of endogenous Rab proteins.
FLAG-Rab7, CD68 and α-tubulin were localised at the periphery of osteoclasts derived from macrophages expressing wild-type or constitutively active FLAG-Rab7, but were localised in the perinuclear region of osteoclasts derived from macrophages expressing the dominant-negative form (Fig. 6b, FLAG-Rab7, DN and 6c). These results indicate that dominant-negative Rab7 suppresses outward lysosome trafficking. Overexpressed dominant-negative Rab proteins are often dispersed throughout the cytoplasm54,55; however, in this study, dominant-negative Rab7 was localised at the perinuclear region with lysosomes in osteoclasts. Our results also indicate that dominant-negative Rab7 suppressed formation of the peripheral microtubule network (Fig. 6b, FLAG-Rab7, α-tubulin). Activated Rab7 can interact with α-tubulin56. Therefore, the peripheral localisation of lysosomes may be required for tethering of microtubules at the cell periphery and, conversely, the peripheral microtubule network may promote accumulation of secretory lysosomes near to the plasma membrane. The same results were obtained when the various forms of Rab7 were expressed after differentiation (Supplementary Fig. S4).
The dominant-negative forms of Rab11B and Rab27A did not affect the localisations of CD68 and α-tubulin (Fig. 6b, FLAG-Rab11B and FLAG-Rab27A, and 6c). The wild-type and constitutively active forms of these Rab proteins also had no effect (Supplementary Fig. S5). These results suggest that Rab11B and Rab27A are not involved in lysosome trafficking in osteoclasts. Therefore, we analysed Rab7 in comparison with Rab11 or Rab27 in subsequent experiments.
Lysosomal localisation of Rab7
We examined the localisation of Rab7 in wild-type and mutant osteoclasts. Rab7 co-localised with CD68 at the periphery of wild-type osteoclasts (Fig. 7a, WT). On the other hand, Rab7 was diffusely located throughout the cytoplasm in a3-knockout osteoclasts and did not co-localise with CD68 (Fig. 7a, a3KO). CD68 was diffused throughout mutant osteoclasts; however, unlike Rab7, it exhibited a clear dot-like staining pattern (Fig. 7a, a3KO). These results suggest that Rab7 fails to associate with CD68-positive compartments upon loss of a3, and thus that a3 is involved in the recruitment of Rab7 to lysosomes.
We examined the localisation of Rab11, a marker of recycling endosomes52, for comparison. In wild-type osteoclasts, Rab11 co-localised with CD68 only at the cell periphery (Fig. 7b, WT), suggesting that secretory lysosomes are formed via the merger of lysosomes and recycling endosomes in osteoclasts, similar to lymphocytes51. In a3-knockout cells, Rab11 and CD68 did not co-localise at the cell periphery (Fig. 7b, a3KO). Recycling endosomes can move to the plasma membrane in a lysosome-independent manner57; however, our results indicate that their peripheral localisation is dependent on lysosome trafficking, at least in osteoclasts. Unlike Rab7, Rab11 had a dot-like staining pattern in mutant osteoclasts (Fig. 7b, a3KO), confirming that a3 is not required for recruitment of Rab11 to recycling endosomes. To quantitatively compare the co-localisation of CD68 and Rab proteins, we determined the percentage of CD68-positive pixels that were also Rab protein-positive in the merged images. Co-localisation of CD68 with Rab7 was significantly lower in mutant cells (~2%) than in wild-type cells (~20%) (Fig. 7c, Rab7). On the other hand, CD68 hardly co-localised with Rab11 in both mutant (~2%) and wild-type (~4%) cells (Fig. 7c, Rab11). These results indicate that a3 promotes the lysosomal localisation of Rab7.
GTP-bound Rab proteins localise in organelle/vesicle membranes35. Therefore, we tested whether a3 is required for lysosomal localisation of constitutively active (GTP-bound) Rab7. In both wild-type and mutant osteoclasts, constitutively active FLAG-Rab7 was expressed at a higher level than the endogenous protein (Fig. 7d, magenta and closed arrows, respectively). In wild-type cells, it localised at the cell periphery together with CD68 and α-tubulin (Fig. 7e, WT). By contrast, in a3-knockout cells, constitutively active FLAG-Rab7 was dispersed throughout the cytoplasm and did not localise to a specific organelle, and the peripheral localisation of CD68 and α-tubulin was not recovered (Fig. 7e, a3KO). These results indicate that a3 is essential for the localisation of GTP-bound Rab7 to secretory lysosomes.
Association of a3 with Rab GTPases
a3 was required for the lysosomal localisation of Rab7 (Fig. 7); therefore, we investigated whether these two proteins directly interact. We co-expressed a FLAG-tagged a subunit isoform (a1, a2 or a3) and a V5-fused Rab7 variant (wild-type, dominant-negative or constitutively active) in HEK293T cells, and performed immunoprecipitations with an anti-FLAG antibody. The catalytic A subunit of V-ATPase was detected in the precipitate (Fig. 8a, A subunit). Given that the A and a subunits are in V1 and Vo, respectively, this result suggests that the FLAG-tagged a subunit and other subunits assembled to form V-ATPase. V5-fused dominant-negative Rab7, but not wild-type or constitutively active Rab7, co-precipitated with FLAG-a3, whereas it was not as efficiently precipitated with the a1 or a2 isoform (Fig. 8a, arrow). These results indicate that dominant-negative Rab7 specifically associates with a3.
We also examined the association of a3 with the dominant-negative forms of Rab11B and Rab27A. Rab27A was immunoprecipitated with a3, whereas no obvious precipitation of Rab11B was observed (Fig. 8b). To further examine the binding specificity, we selected other small GTP-binding proteins from different subfamilies. Although Rac, Ran and H-Ras were expressed at a similar level as Rab7, they were not immunoprecipitated with a3 (Fig. 8c).
Unexpectedly, we detected an association between a3 and Rab27A. This prompted us to examine whether a3 is required for lysosomal localisation of this Rab protein. FLAG-Rab27A localised diffusively in mutant osteoclasts, whereas it co-localised with CD68 at the periphery of wild-type cells (Supplementary Fig. S4b,c). This suggests that a3 is also involved in the recruitment of Rab27A to lysosomes.
Taken together, a3 interacts specifically with the dominant-negative forms of Rab7 and Rab27A. Given that these forms mimic GDP-bound Rab proteins, GDP-bound Rab7 may be recruited to lysosomes via a direct interaction with a3, and, after nucleotide exchange, the activated Rab proteins may associate with microtubules for trafficking to the cell periphery (Fig. 8d).
Discussion
This study revealed an unexpected mechanistic link between the a3 isoform of V-ATPase and Rab7 in osteoclasts. Therefore, a3 has dual functions in osteoclasts; it is not only an essential isoform of the proton pump, but is also involved in secretory lysosome trafficking.
Rab7 localised to lysosomes in an a3-dependent manner, and its dominant-negative (GDP-bound) form specifically interacted with a3. These results suggest that a3 recruits GDP-bound Rab7 from the cytosol to secretory lysosomes. After its activation, GTP-bound Rab7 associates with microtubules to mediate trafficking (Fig. 8d, WT). Lysosomes lacking a3 did not recruit GDP-bound Rab7 and hence were not transported to the cell periphery (Fig. 8d, a3KO). Unexpectedly, a3 was also required for the lysosomal localisation of activated Rab7 (Fig. 8d, a3KO).
Levels of lysosome-specific a3, which is a component of the Vo sector, a ubiquitous B2 isoform, which is a component of the V1 sector, and the d2 isoform, which connects the Vo and V1 sectors, increase during differentiation of progenitors into osteoclasts30. As described above, the catalytic A subunit of V1 was immunoprecipitated with a3. These results suggest that a3 forms V-ATPase together with other subunits in secretory lysosomes and recruits a sufficient amount of Rab7 to tightly anchor lysosomes to microtubules for long-range delivery to the cell periphery.
Rab7 regulates late endosome/lysosome trafficking in both outward and inward directions. Several factors are involved in trafficking together with Rab7. Rab-interacting lysosomal protein (RILP) collaborates with Rab7 as an adaptor for the motor protein dynein, which moves in an inward direction along microtubules56. FYVE and coiled-coil domain-containing 1 (FYCO1) is an adaptor for the motor protein kinesin, which moves in an outward direction56. Thus, FYCO1 is hypothesised to function in trafficking of secretory lysosomes.
Guanine nucleotide exchange factors (GEFs) are other essential proteins for organelle transport regulated by small GTPases. These factors bind to the corresponding GDP-bound Rab protein and activate it by exchanging GDP for GTP34,35,58. Therefore, the complex containing a3 and Rab7 likely has GEF activity for Rab7. Although this complex may include the factors discussed above, they were omitted from the model for simplicity (Fig. 8d). The Mon1-Ccz1 complex is the GEF for Rab759. However, a recent study concerning on macropinocytosis induced in Cos-7 cells demonstrated that Mon1-Ccz1 is recruited to late endosomes but subsequently detaches from lysosomes60. This previous study also indicates that Ccz1 depletion does not affect lysosome positioning that requires Rab7 activation60. These findings suggest that Mon1-Ccz1 is not involved in activation of lysosomal Rab7. Further studies are required to fully elucidate the lysosome trafficking mechanism, including the roles of the Rab7 GEF and its interaction with a3.
The specific interaction between a3 and GDP-bound Rab27A (Fig. 8) and the a3-dependent lysosomal localisation of Rab27A (Supplementary Fig. S5b,c) suggest that a3 also recruits this protein to the lysosomal membrane. Recent studies of lysosomal secretion in cytotoxic T lymphocytes revealed that Rab27A is involved in docking and fusion between secretory vesicles and the plasma membrane51. More recently, Rab27A was suggested to play a role in the transport of cell surface receptors in osteoclasts40. Taken together, a3 is likely involved in docking and fusion between secretory lysosomes and the plasma membrane via recruitment of Rab27A.
Secretion via lysosomes and related organelles is observed in various types of cells, such as cytotoxic T lymphocytes, melanocytes, platelets and spermatids3–6. a3 is a ubiquitously expressed lysosome-specific isoform17,61. Therefore, a3 is likely involved in trafficking of secretory lysosomes in these cells. In addition, insulin secretion by β cells in Langerhans islets is decreased in a3-knockout mice62. a3 is found in insulin secretory granules and other endocrine tissues62,63, although they are not lysosome-related organelles. Therefore, the mechanisms underlying regulated secretion may be similar to that underlying lysosomal secretion in osteoclasts. On the other hand, V-ATPase in lysosome-related organelle is suggested to be involved in inward trafficking in HeLa cells based on the finding that loss of its function promotes secretion of multivesicular bodies in the cells64. Thus, V-ATPase plays a role in both outward and inward trafficking of lysosomes and lysosome-related organelles. This is consistent with the fact that Rab7 regulates both outward and inward trafficking. The direction of the trafficking appears to be dependent on the cell types.
a3 knockout did not affect the localisations of early endosomes and the Golgi in osteoclasts. The a1 and a2 isoforms localise in coated vesicles and early endosomes/Golgi, respectively24–26. Neither isoform could perform the role of a3 in lysosome trafficking in osteoclasts. These results indicate that the three isoforms have independent roles in organelle trafficking and positioning. In this regard, previous studies reported the role of the a1 and a2 isoforms in intracellular trafficking pathways. In Drosophila central neurons, a1 has an essential role in secretion of neurotransmitter from synaptic vesicles65. In mouse kidney proximal cells, a2 in early endosomes is involved in vesicle trafficking from early to late endosomes during endocytosis of macromolecules66. a2 recruits ADP-ribosylation factor nucleotide site operator (ARNO), a GEF for the small GTPase Arf6, which facilitate vesicle trafficking from early to late endosomes66,67.
Altogether, organelle-specific a subunit isoforms play an important role in determining the direction of organelle trafficking by recruiting specific co-factors including small GTPases. Further studies of the roles of V-ATPase isoforms will establish the mechanism underlying organelle trafficking.
Methods
Animals and cell culture
Wild-type and a3-knockout mice were generated as described previously30,68. Briefly, C57BL/6-a3+/− mice (BRC no. 04421) were obtained from RIKEN BioResource Center and crossed to generate C57BL/6-a3+/+ (wild-type) and C57BL/6-a3−/− (a3-knockout) mice. a3-knockout mice lack exons 15–20 of the a3 gene68. Macrophages were obtained as adherent cells after incubation of splenic cells from 2-week-old mice (male and female) in Minimum Essential Medium alpha (MEMα) supplemented with 10% foetal bovine serum, 100 U/mL penicillin, 100 μg/mL streptomycin and 25 ng/mL macrophage colony-stimulating factor (R&D Systems) for 3 days30. To induce osteoclast differentiation, splenic macrophages were cultured in the same medium containing 200 ng/mL RANKL (Peprotech) for 4 days30. Animals were used under the Guidelines for the Animal Experiments of Iwate Medical University and the Act on Welfare and Management of Animals of Japan. Animal protocols were approved by the Ethics Committee for Animal Research of Iwate Medical University (approval number: 28-017). HEK293T and Plat-E cells were purchased from RIKEN BioResource Center (RCB2202) and Cell Biolab, respectively. These cells were cultured in Dulbecco’s Modified Eagle Medium containing 10% foetal bovine serum, 100 U/mL penicillin and 100 μg/mL streptomycin. Unless otherwise indicated, all reagents used for cell culture were from Life Technologies. For the pit formation assay, osteoclasts were cultured on calcium phosphate-coated dishes (CORNING)30.
Antibodies
Antibody information can be found in Supplementary Table S1. Antibodies against CD68 (FA-11), Rab27A and V5 were purchased from Hycult Biotechnology (HM1070), Proteintech (17817-1-AP) and Life Technologies (R96025), respectively. Antibodies to GM130 (618022) and LAMP1 (553792) were purchased from BD Biosciences Pharmingen. Antibodies against α-tubulin (DM1A, T9026), β-actin (AC-15, A5441) and FLAG (F7425) were from SIGMA. Anti-Rab7 (D95F2, 9367) and anti-Rab11 (D4F5, 5589) were obtained from Cell Signaling. Antibodies against cathepsin K (E-7, sc-48353) and GFP (B-2, sc-9996) were from Santa Cruz. Antibodies against a1, a2 and a3 were generated as described previously30,61,69. Alexa-conjugated secondary antibodies (A11034, A11029, A11081 and A21236) and colloidal gold-conjugated ones (EMGAT10 and EMGMHL5) were from Life Technologies and BBI solutions, respectively. HRP-conjugated antibodies to rabbit IgG (NA934VS), mouse IgG (NA931VS), chicken IgY (12–341) and native primary antibodies (21230) were purchased from GE healthcare (anti-rabbit IgG and mouse IgG), Millipore and Thermo Scientific.
Electron microscopy
Two-week-old wild-type and a3-knockout mice were anesthetised and perfused with phosphate-buffered saline (137 mM NaCl, 27 mM KCl, 81 mM Na2HPO4 and 14.7 mM KH2PO4, pH 7.4) containing 4% paraformaldehyde. Humeri were isolated and soaked in 0.1 M phosphate buffer containing 2% paraformaldehyde and 2.5% glutaraldehyde overnight for ordinary electron microscopy or 4% paraformaldehyde for 4 h at 4 °C for immunogold electron microscopy. Fixed specimens were immersed in EDTA solution (9% EDTA-2Na-2H20 and 10% EDTA-4Na-4H2O) at 4 °C for 1 week17.
For ordinary electron microscopy, osmification was carried out in 1% (w/v) osmium tetroxide solution, and decalcified bone tissues were dehydrated using a graded ethanol series and embedded in Epon812 (TAAB Laboratories). Ultrathin sections were cut using an ultramicrotome, stained with lead citrate plus uranyl acetate and then examined with a transmission electron microscope (H-7650, Hitachi)70.
Immunogold electron microscopy was carried out as described previously71. Briefly, samples were infused with 0.1 M phosphate buffer (pH 7.0) containing 20% polyvinylpyrrolidone and 1.8 M sucrose for 2 h at room temperature, incubated overnight at 4 °C and frozen at −190 °C using rapid-freezing apparatus (KF-80, Leica). Ultrathin cryosections were cut on an ultramicrotome (UCT or UC6, Leica) equipped with a cryoattachment (FCS or FC6, Leica). The sections were mounted on carbon-coated grids and incubated with primary antibodies (rat anti-CD68 (1:100) and mouse anti-cathepsin K (1:100)) at 4 °C for 48 h. After washing, the sections were incubated with a colloidal gold (10 nm)-conjugated anti-rat IgG antibody (BBI, 1:100) and/or a gold (5 nm)-conjugated anti-mouse IgG antibody (BBI, 1:100) at room temperature for 2 h. The grids were coated with poly(vinyl alcohol) containing 0.1% uranyl acetate and observed with an electron microscope (H-7650, Hitachi).
Fluorescence microscopy
Immunostaining was performed as described17. Cells were fixed with 4% paraformaldehyde for 30 min and permeabilised in phosphate-buffered saline containing 0.4% saponin, 1% bovine serum albumin and 2% normal goat serum at room temperature for 15 min. Cells were incubated with primary antibodies at 4 °C overnight and then with fluorescent dye-conjugated secondary antibodies (Life Technologies) at room temperature for 1 h. F-actin was visualised with Alexa647-conjugated phalloidin (Life Technologies)17,30. Endocytosis and cholesterol localisation were examined using FITC-dextran (Life Technologies)46 and filipin (SIGMA)47, respectively. Fluorescence images were acquired with FV-1000 Confocal Microscope (OLYMPUS).
ELISAs
Macrophages obtained from wild-type and a3-knockout mice were incubated with 100 ng/mL highly purified LPS (TLR grade, Alexis Biochemicals) for 8 or 24 h. After treatment, the culture media were collected and cell lysates were prepared45. ELISAs for IL6 and IL10 were performed as described in the manufacturer’s protocol (Thermo Scientific). Cytokine secretion (%) was defined as the amount in the culture medium relative to the total amount in the culture medium and cell lysate.
Construction of plasmids
To construct a recombinant plasmid for expression of mouse a3, a DNA fragment encoding FLAG-tagged a3 was PCR-amplified using the pKT-mouse a3 plasmid66 as a template and primers a3_FW and a3_RV (Supplementary Table S2), and cloned into pcDNA3.1 using KpnI and NotI. Recombinant plasmids for expression of FLAG-a1 and FLAG-a2 were generated by replacing the coding region of a3 in pcDNA3.1 with that of a1 or a2 in pKT69. To construct the V5-tagged Rab7 expression plasmid, a DNA fragment encoding Rab7 was obtained by reverse transcriptase-polymerase chain reaction (RT-PCR) using total RNA isolated from RAW264.7 cells and primers with a BamHI or NotI site (Supplementary Table S2), and digested with BamHI and NotI. The fragment and a V5-tag linker with KpnI and BamHI sites were subcloned into pcDNA3.1 using KpnI and NotI. Expression plasmids for other mouse small GTPases (Rab11B, Rab27A, Rac1, Ran and H-Ras) were created by replacing the Rab7 coding region with the DNA fragment encoding each gene, which was amplified by RT-PCR using the respective primers (Supplementary Table S2).
For retrovirus infection, FLAG-a3 and FLAG-Rab7, FLAG-Rab11B and FLAG-Rab27A were subcloned from pcDNA3.1 into the pMX(puro) plasmid by ligating the fragments digested with BamHI and NotI. Dominant-negative and constitutively active mutations of small GTPases were introduced into the recombinant plasmids by oligonucleotide-directed site-specific mutagenesis PCR (Supplementary Table S2). EGFP-tagged Rab7 and mutant cDNAs were subcloned into the pAd/PL-DESTTM Gateway Vector for adenovirus construction (Invitrogen). The wild-type, dominant-negative and constitutively active forms of Rab7 were fused to the carboxyl terminal of GFP under the control of the cytomegalovirus promoter.
Transfection and virus infection
HEK293T and Plat-E cells were transfected using ExtremeGENE9 (SIGMA) as described in the manufacturer’s protocol. Splenic macrophages were infected with retroviruses using a Platinum Retrovirus Expression System (Cell Biolab). Infected cells were selected in MEMα containing 2 μg/mL puromycin for 2 days, cultured for a further 2 days in the absence of the antibiotic and then incubated with 200 ng/mL RANKL for 6 days. Infected macrophages were incubated with RANKL for longer than non-infected macrophages because osteoclast differentiation occurred more slowly after retrovirus infection and selection with puromycin. Recombinant adenoviruses were constructed using the ViraPower Adenoviral Gateway Expression Kit (Invitrogen). The obtained adenoviruses were used to express EGFP-Rab7 variants in osteoclasts induced from macrophages.
Immunoprecipitation assay and Western blotting
HEK293T cells were transfected with plasmids encoding a FLAG-tagged subunit a isoform and a V5-tagged small GTPase, lysed in IP buffer (1% Triton X-100, 10% glycerol, 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA, 1 mM phenylmethanesulfonyl fluoride and protease inhibitor cocktails) and immunoprecipitated with an anti-FLAG antibody as described previously30,72. Immunoprecipitates were analysed by Western blotting using Clean Blot (Thermo Scientific) as a secondary antibody. HRP-conjugated host-specific secondary antibodies (GE Healthcare) were used for Western blotting of macrophage and osteoclast lysates. Immune complexes were detected by chemiluminescence using an ECL prime detection kit (GE Healthcare) and an LAS-3000 imaging system (FUJIFILM).
Quantitative analysis
To analyse the distribution of CD68 in electron microscopy images, the number of colloidal gold particles was counted in 30 randomly selected fields (1.4 μm2/field) of each area (ruffled border and cytoplasm). Ten randomly selected cells were analysed. In total, at least 1200 gold particles were counted in both wild-type and mutant osteoclasts.
To quantify the distribution of CD68 in confocal microscopy images, an image of a differentiated cell was divided into 16 sections using the shape of the cell outline. The width of each section was 2 μm. Thereafter, the fluorescence intensity of CD68 staining in each section was measured using Image-J software (NIH)73.
The signal fluorescence intensities (FITC-dextran and filipin), area of bone resorption pits and signal intensity of Western blotting were also quantified using Image-J. Cells fixed before addition of FITC-dextran were used as a negative control in the analysis of endocytosis. To determine the intracellular background labelling of filipin, the fluorescence intensities in three randomly selected areas (0.96 μm2/area) near to the plasma membrane were averaged as described previously47. Co-localisation of CD68 with Rab proteins or FITC-dextran was examined using a confocal FV-1000 microscope74,75.
Statistics and reproducibility
The F-test and unpaired two-tailed Student’s t-test were performed using Microsoft Excel software for statistical comparisons. p < 0.05 was considered statistically significant. When representative images are shown, the numbers of samples examined are all indicated in the figure legends. All replications were successful, provided that progenitors differentiated into osteoclasts.
Data availability
Source data for Figs 2c, 3e, 4b, 5a–c, 6c, 7c, S1a–b and S2b has been provided in Supplementary Table S3. All other data supporting the findings of this study are available from the authors on reasonable request.
Electronic supplementary material
Acknowledgements
This work was supported partly by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Number JP15K07939, JP18K06661 (to M.N.-M.), JP16K18877, JP18K06629 (to M.S.) and JP16K07357 (to N.M.). This study was also supported by Keiryokai Research Foundation, the Terumo Life Science Foundation, the Japan Foundation for Applied Enzymology, the Hayashi Memorial Foundation for Female Natural Scientists (to M.N.-M.) and individual Research Grants in Doshisha Women’s College of Liberal Arts (to G.-H.S.-W.). We thank Ms. Shio Yano, Kikuko Kawano and Kinji Ishida for their expert technical assistance.
Author Contributions
N.M. and M.N.-M. conceived the study and designated the experiments with input from all authors. N.M. performed most experiments and data analysis. K.T. and E.I.-M. carried out electron microscopy and morphological data analysis. M.S. and M.N.-M. performed immunoprecipitation and ELISA experiments, respectively. Y.W. and G.-H.S.-W. generated a3-knockout mice and adenoviruses carrying genes of Rab7 variants. M.N.-M., M.F. and N.M. wrote the manuscript with input from all authors. M.N.-M. coordinated the project.
Competing Interests
The authors declare no competing interests.
Footnotes
Electronic supplementary material
Supplementary information accompanies this paper at 10.1038/s41598-018-24918-7.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.McMahon HT, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 2011;12:517–533. doi: 10.1038/nrm3151. [DOI] [PubMed] [Google Scholar]
- 2.Luzio JP, Parkinson MD, Gray SR, Bright NA. The delivery of endocytosed cargo to lysosomes. Biochem. Soc. Trans. 2009;37:1019–1021. doi: 10.1042/BST0371019. [DOI] [PubMed] [Google Scholar]
- 3.Luzio JP, Pryor PR, Bright NA. Lysosomes: fusion and function. Nat. Rev. Mol. Cell Biol. 2007;8:622–632. doi: 10.1038/nrm2217. [DOI] [PubMed] [Google Scholar]
- 4.Luzio JP, Hackmann Y, Dieckmann NM, Griffiths GM. The biogenesis of lysosomes and lysosome-related organelles. Cold Spring Harb. Perspect. Biol. 2014;6:a016840. doi: 10.1101/cshperspect.a016840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Chen D, Lemons PP, Schraw T, Whiteheart SW. Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 and 4 in lysosome release. Blood. 2000;96:1782–1788. [PubMed] [Google Scholar]
- 6.Kierszenbaum AL, Tres LL, Rivkin E, Kang-Decker N, van Deursen JM. The acroplaxome is the docking site of Golgi-derived myosin Va/Rab27a/b-containing proacrosomal vesicles in wild-type and Hrb mutant mouse spermatids. Biol. Reprod. 2004;70:1400–1410. doi: 10.1095/biolreprod.103.025346. [DOI] [PubMed] [Google Scholar]
- 7.Mark MS, Seabra MC. The melanosome: membrane dynamics in black and white. Nat. Rev. Mol. Cell Biol. 2001;2:738–748. doi: 10.1038/35096009. [DOI] [PubMed] [Google Scholar]
- 8.Peters PJ, et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 1991;173:1099–1109. doi: 10.1084/jem.173.5.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Burkhardt JK, Hester S, Lapham CK, Argon Y. The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments. J. Cell Biol. 1990;111:2327–2340. doi: 10.1083/jcb.111.6.2327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Huizing M, Helip-Wooley A, Westbroek W, Gunay-Aygun M, Gahl WA. Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. Annu. Rev. Genomics Hum. Genet. 2008;9:359–386. doi: 10.1146/annurev.genom.9.081307.164303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Stinchcombe J, Bossi G, Grrifiths GM. Linking albinism and immunity: the secret of secretory lysosomes. Science. 2004;305:55–59. doi: 10.1126/science.1095291. [DOI] [PubMed] [Google Scholar]
- 12.Zhao H. Membrane trafficking in osteoblasts and osteoclasts: new avenues for understanding and treating skeletal diseases. Traffic. 2012;13:1307–1314. doi: 10.1111/j.1600-0854.2012.01395.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 2007;7:292–304. doi: 10.1038/nri2062. [DOI] [PubMed] [Google Scholar]
- 14.Feng X, Teitelbaum SL. Osteoclasts: New Insights. Bone Res. 2013;29:11–26. doi: 10.4248/BR201301003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289:1504–1508. doi: 10.1126/science.289.5484.1504. [DOI] [PubMed] [Google Scholar]
- 16.Väänänen HK, Zhao H, Mulari M, Halleen JM. The cell biology of osteoclast function. J. Cell Sci. 2000;113:377–381. doi: 10.1242/jcs.113.3.377. [DOI] [PubMed] [Google Scholar]
- 17.Toyomura T, et al. From lysosomes to the plasma membrane: localization of vacuolar-type H+-ATPase with the a3 isoform during osteoclast differentiation. J. Biol. Chem. 2003;13:22023–22030. doi: 10.1074/jbc.M302436200. [DOI] [PubMed] [Google Scholar]
- 18.Blair HC, Teitelbaum SL, Ghiselli R, Gluck S. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science. 1989;245:855–857. doi: 10.1126/science.2528207. [DOI] [PubMed] [Google Scholar]
- 19.van Meel E, et al. Disruption of the Man-6-P targeting pathway in mice impairs osteoclast secretory lysosome biogenesis. Traffic. 2011;12:912–924. doi: 10.1111/j.1600-0854.2011.01203.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Lacombe J, Karsenty G, Ferron M. Regulation of lysosome biogenesis and functions in osteoclasts. Cell Cycle. 2013;12:2744–2752. doi: 10.4161/cc.25825. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Baron R, Neff L, Louvard D, Courtoy PJ. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J. Cell Biol. 1985;101:2210–2222. doi: 10.1083/jcb.101.6.2210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Maxson ME, Grinstein S. The vacuolar-type H+-ATPase at a glance – more than a proton pump. J. Cell Sci. 2014;127:4987–4993. doi: 10.1242/jcs.158550. [DOI] [PubMed] [Google Scholar]
- 23.Breton S, Brown D. Regulation of luminal acidification by the V-ATPase. Phisiology (Bethesda) 2013;28:318–329. doi: 10.1152/physiol.00007.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Forgac M. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol. 2007;8:917–929. doi: 10.1038/nrm2272. [DOI] [PubMed] [Google Scholar]
- 25.Toei M, Saum R, Forgac M. Regulation and isoform function of the V-ATPases. Biochemistry. 2010;49:4715–4723. doi: 10.1021/bi100397s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Futai M, Nakanishi-Matsui M, Okamoto H, Sekiya M, Nakamoto RK. Rotational catalysis in proton pumping ATPase: from E. coli F-ATPase to mammalian V-ATPase. Biochim. Bhiophys. Acta. 2012;1817:1711–1721. doi: 10.1016/j.bbabio.2012.03.015. [DOI] [PubMed] [Google Scholar]
- 27.Smith, A. N., Borthwick, K. J. & Karet, F. E. Molecular cloning and characterization of novel tissue-specific isoforms of the human vacuolar H(+)-ATPase C, G and d subunits, and their evaluation in autosomal recessive distal renal tubular acidosis. Gene 169–177 (2002). [DOI] [PubMed]
- 28.Smith AN, et al. Vacuolar H+-ATPase d2 subunit: molecular characterization, developmental regulation, and localization to specialized proton pumps in kidney and bone. J. Am. Soc. Nephrol. 2005;16:1245–1256. doi: 10.1681/ASN.2004090761. [DOI] [PubMed] [Google Scholar]
- 29.Wu H, Xu G, Li YP. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption. J. Bone. Mener. Res. 2009;24:871–885. doi: 10.1359/jbmr.081239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Matsumoto N, et al. Diversity of proton pumps in osteoclasts: V-ATPase witha3 and d2 isoforms is a major form in osteoclasts. Biochim. Biophys. Acta. 2014;1837:774–749. doi: 10.1016/j.bbabio.2014.02.011. [DOI] [PubMed] [Google Scholar]
- 31.Frattini A, et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat. Genet. 2000;25:343–346. doi: 10.1038/77131. [DOI] [PubMed] [Google Scholar]
- 32.Li YP, Chen W, Liang Y, Li E, Stashenko P. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat. Genet. 1999;23:447–451. doi: 10.1038/70563. [DOI] [PubMed] [Google Scholar]
- 33.Scimeca JC, et al. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone. 2000;26:207–213. doi: 10.1016/S8756-3282(99)00278-1. [DOI] [PubMed] [Google Scholar]
- 34.Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 2009;10:513–525. doi: 10.1038/nrm2728. [DOI] [PubMed] [Google Scholar]
- 35.Bhuin T, Roy JK. Rab proteins: the key regulators of intracellular vesicle transport. Exp. Cell Res. 2014;328:1–19. doi: 10.1016/j.yexcr.2014.07.027. [DOI] [PubMed] [Google Scholar]
- 36.Bock JB, Matern HT, Peden AA, Scheller RH. A genomic perspective on membrane compartment organization. Nature. 2001;409:839–841. doi: 10.1038/35057024. [DOI] [PubMed] [Google Scholar]
- 37.Pereira-Leal JB, Seabra MC. Evolution of the Rab family of small GTP-binding proteins. J. Mol. Biol. 2001;313:889–901. doi: 10.1006/jmbi.2001.5072. [DOI] [PubMed] [Google Scholar]
- 38.Müller, M. P. & Goody, R. S. Molecular control of Rab activity by GEFs, GAPs and GDI. Small GTPases 1–17 (2017). [DOI] [PMC free article] [PubMed]
- 39.Zhao H, Laitala-Leinonen T, Parikka V, Väänänen HK. Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption. J. Biol. Chem. 2001;276:39295–39302. doi: 10.1074/jbc.M010999200. [DOI] [PubMed] [Google Scholar]
- 40.Shimada-Sugawara M, et al. Rab27A regulates transport of cell surface receptors modulating multinucleation and lysosome-related organelles in osteoclasts. Sci. Rep. 2015;5:9620. doi: 10.1038/srep09620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Nakamura I, et al. Lack of vacuolar proton ATPase association with the cytoskeleton in osteoclasts of osteosclerotic (oc/oc) mice. FEBS Lett. 1997;401:207–212. doi: 10.1016/S0014-5793(96)01454-8. [DOI] [PubMed] [Google Scholar]
- 42.Palokangas H, Mulari M, Väänänen HK. Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts. J. Cell Sci. 1997;110:1767–1780. doi: 10.1242/jcs.110.15.1767. [DOI] [PubMed] [Google Scholar]
- 43.Nakamura N, et al. Characterization of a cis-Golgi matrix protein, GM130. J. Cell Biol. 1995;131:1715–1726. doi: 10.1083/jcb.131.6.1715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Mu FT, et al. EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine “fingers” and contains a calmodulin-binding IQ motif. J. Biol. Chem. 1995;270:13503–13511. doi: 10.1074/jbc.270.22.13503. [DOI] [PubMed] [Google Scholar]
- 45.Nakanishi-Matsui M, Yano S, Futai M. Lipopolysaccharide-induced multinuclear cells: increased internalization of polystyrene beads and possible singals for cell fusion. Biochem. Biophys. Res. Commun. 2013;440:611–616. doi: 10.1016/j.bbrc.2013.09.109. [DOI] [PubMed] [Google Scholar]
- 46.Stenbeck G, Horton MA. Endocytic trafficking in actively resorbing osteoclasts. J. Cell Sci. 2004;117:827–836. doi: 10.1242/jcs.00935. [DOI] [PubMed] [Google Scholar]
- 47.Li X, et al. A molecular mechanism to regulate lysosome motility for lysosome positioning and tubulation. Nat. Cell Biol. 2016;18:404–417. doi: 10.1038/ncb3324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front. Immunol. 2014;5:491. doi: 10.3389/fimmu.2014.00491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Zhang M, Chen L, Wang S, Wang T. Rab7: roles in membrane trafficking and disease. Biosci. Rep. 2009;29:193–209. doi: 10.1042/BSR20090032. [DOI] [PubMed] [Google Scholar]
- 50.Fukuda M. Regulation of secretory vesicle traffic by Rab small GTPases. Cell. Mol. Life Sci. 2008;65:2801–2813. doi: 10.1007/s00018-008-8351-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.van der Sluijs P, Zibouche M, van Lerkhof P. Late steps in secretory lysosome exocytosis in cytotoxic lymphocytes. Front. Immunol. 2013;18:359. doi: 10.3389/fimmu.2013.00359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Ullrich O, Reinsch S, Urbé S, Zerial M, Parton RG. Rab11 regulates recycling through the pericentriolar recycling endosome. J. Cell Biol. 1996;135:913–924. doi: 10.1083/jcb.135.4.913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Zhao H, Ettala O, Väänänen HK. Intracellular membrane trafficking pathways in bone-resorbing osteoclasts revealed by cloning and subcellular localization studies of small GTP-binding rab proteins. Biochem. Biophys. Res. Commun. 2002;10:1060–1065. doi: 10.1016/S0006-291X(02)00326-1. [DOI] [PubMed] [Google Scholar]
- 54.Guteirrez MG, Munafó DB, Berón W, Colombo MI. Rab7 is required for the normal progression of the autophagic pathway in mammalian cells. J. Cell Sci. 2004;117:2687–2697. doi: 10.1242/jcs.01114. [DOI] [PubMed] [Google Scholar]
- 55.Starr T, Ng TW, Wehrly TD, Knodler LA, Celli J. Brucella intracellular replication requires trafficking through the late endosomal/lysosomal compartment. Traffic. 2008;9:678–694. doi: 10.1111/j.1600-0854.2008.00718.x. [DOI] [PubMed] [Google Scholar]
- 56.Pu J, Guardia CM, Keren-Kaplan T, Bonifacino JS. Mechanisms and functions of lysosome positioning. J Cell Sci. 2016;129:4329–4339. doi: 10.1242/jcs.196287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Goldenring JR. Recycling endosomes. Curr. Opin. Cell Biol. 2015;35:117–122. doi: 10.1016/j.ceb.2015.04.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell. 2007;129:865–877. doi: 10.1016/j.cell.2007.05.018. [DOI] [PubMed] [Google Scholar]
- 59.Nordmann M, et al. The Mon1-Ccz1 complex is the GEF of the late endosomal Rab7 homolog Ypt7. Curr. Biol. 2010;20:1654–1659. doi: 10.1016/j.cub.2010.08.002. [DOI] [PubMed] [Google Scholar]
- 60.Yasuda S, et al. Mon1-Ccz1 activates Rab7 only on late endosomes and dissociates from the lysosome in mammalian cells. J. Cell Sci. 2016;129:329–340. doi: 10.1242/jcs.178095. [DOI] [PubMed] [Google Scholar]
- 61.Toyomura T, Oka T, Yamaguchi C, Wada Y, Futai M. Three subunit a isoforms of mouse vacuolar H(+)-ATPase. Preferential expression of the a3 isoform during osteoclast differentiation. J. Biol. Chem. 2000;275:8760–8765. doi: 10.1074/jbc.275.12.8760. [DOI] [PubMed] [Google Scholar]
- 62.Sun-Wada GH, et al. Thea3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. J. Cell Sci. 2006;119:4531–4540. doi: 10.1242/jcs.03234. [DOI] [PubMed] [Google Scholar]
- 63.Sun-Wada GH, Tabata H, Kawamura N, Futai M, Wada Y. Differential expression of a subunit isoforms of the vacuolar-type proton pump ATPase in mouse endocrine tissues. Cell Tissue Res. 2007;329:239–248. doi: 10.1007/s00441-007-0421-7. [DOI] [PubMed] [Google Scholar]
- 64.Edgar JR, Manna PT, Nishimura S, Banting G, Robinson MS. Tetherin is an exosomal tether. Elife. 2016;5:e17180. doi: 10.7554/eLife.17180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Hiesinger PR, et al. The v-ATPase V0 subunita1 is required for a late step in synaptic vesicle exocytosis inDrosophila. Cell. 2005;121:607–620. doi: 10.1016/j.cell.2005.03.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Hurtado-Lorenzo A, et al. V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat. Cell Biol. 2006;8:124–136. doi: 10.1038/ncb1348. [DOI] [PubMed] [Google Scholar]
- 67.Marshansky V, Futai M. The V-type H+-ATPase in vesicular trafficking: targeting, regulation and function. Curr. Opin. Cell Biol. 2008;20:415–426. doi: 10.1016/j.ceb.2008.03.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Sun-Wada GH, Tabata H, Kawamura N, Aoyama M, Wada Y. Direct recruitment of H+-ATPase from lysosomes for phagosomal acidification. J. Cell Sci. 2009;122:2504–2513. doi: 10.1242/jcs.050443. [DOI] [PubMed] [Google Scholar]
- 69.Sun-Wada GH, et al. Generation of chicken monoclonal antibodies against thea1, a2, and a3 subunit isoforms of vacuolar-type proton ATPase. Hybridoma (Larchmt) 2011;30:199–203. doi: 10.1089/hyb.2010.0087. [DOI] [PubMed] [Google Scholar]
- 70.Ohka S, et al. Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome. J. Virol. 2004;78:7186–7198. doi: 10.1128/JVI.78.13.7186-7198.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Akagi T, et al. Improved methods for ultracryotomy of CNS tissue for ultrastructural and immunogold analyses. J. Neurosci. Methods. 2006;153:276–283. doi: 10.1016/j.jneumeth.2005.11.007. [DOI] [PubMed] [Google Scholar]
- 72.Matsumoto N, Tamura S, Fujiki Y. The pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA ATPase complexes to peroxisomes. Nat. Cell Biol. 2003;5:454–460. doi: 10.1038/ncb982. [DOI] [PubMed] [Google Scholar]
- 73.Abramoff MD, Magelhaes PJ, Ram SJ. Image Processing with ImageJ. Biophotonics International. 2004;11:36–42. [Google Scholar]
- 74.Chiu WT, Tang MJ, Jao HC, Shen MR. Soft substrate up-regulates the interaction of STIM1 with store-operated Ca2+ channels that lead to normal epithelial cell apoptosis. Mol. Biol. Cell. 2008;19:2220–2230. doi: 10.1091/mbc.E07-11-1170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Yeh YC, Wu CC, Wang YK, Tang MJ. DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin. Mol. Biol. Cell. 2011;22:940–953. doi: 10.1091/mbc.E10-08-0678. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Source data for Figs 2c, 3e, 4b, 5a–c, 6c, 7c, S1a–b and S2b has been provided in Supplementary Table S3. All other data supporting the findings of this study are available from the authors on reasonable request.